Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids

Study Background and Research Question

The sinoatrial node (SAN) serves as the primary pacemaker of the human heart, orchestrating rhythmic electrical impulses that initiate each heartbeat and govern cardiac output. Although the fundamental principles of SAN function and development have been elucidated in animal models, significant interspecies differences in electrophysiology and autonomic modulation limit their translational relevance. Human cardiac research has been further constrained by limited access to SAN tissue and the inherent complexity of its intramural 3D architecture. A critical gap has persisted in modeling neuro-cardiac interactions—particularly the influence of intrinsic cardiac ganglia on pacemaker maturation—in a human-relevant system. The reference study directly addresses this gap by developing a human pluripotent stem cell (hPSC)-derived model that integrates SAN and cardiac plexus organoids, forming SAN-plexus assembloids capable of recapitulating key features of neurogenic pacemaker maturation (reference study).

Key Innovation from the Reference Study

The central innovation lies in the assembly of a tri-organoid system, combining hPSC-derived SAN organoids (SANOs), cardiac ganglionated plexus organoids (CGPOs), and atrial-like cardiac organoids to construct a functional model of pacemaker-to-atrial conduction. This assembloid approach preserves the 3D spatial organization, cellular heterogeneity, and intrinsic neural innervation essential for authentic SAN physiology. By leveraging spatial transcriptomic integration with ex vivo human SAN tissue, the study identifies a neuron-to-pacemaker signaling axis driven by CGPO-derived prosaposin (PSAP) acting on the SAN-enriched receptor GPR37, thereby elucidating a molecular mechanism underlying pacemaker maturation and autonomic regulation.

Methods and Experimental Design Insights

The investigators developed their model by differentiating hPSCs into SAN-like pacemaker cells, cardiac ganglionated plexus neuron populations, and atrial-type cardiomyocytes. These organoids were merged into multi-component assembloids, enabling precise spatial and cellular architecture reminiscent of the native SAN complex. Functional interrogation included electrophysiological assessments, high-resolution calcium imaging, and transcriptomic profiling. Notably, the integration of spatial transcriptomics with assembloid-based assays permitted direct comparison of molecular and functional features between the in vitro system and human SAN tissue. The use of selective pathway perturbations—such as modulating PSAP-GPR37 signaling—further allowed dissection of neuron-to-pacemaker communication.

Protocol Parameters

• Assembloid construction: Sequential co-aggregation of SAN organoids, CGPOs, and atrial-like organoids to mimic anatomical coupling.
• Electrophysiological recordings: Patch-clamp and optical mapping performed after stable assembloid formation, typically 2-3 weeks post-assembly, to assess pacemaker activity and conduction.
• Beta-adrenergic receptor signaling assessment: Acute application of non-selective beta-adrenergic agonists—such as isoproterenol hemisulfate—enables evaluation of autonomic modulation of SAN firing rates (see related internal protocols: Isoproterenol Sulfate Dihydrate: Powering Pacemaker Maturation Models).
• Transcriptomic analysis: Single-cell and spatial RNA sequencing to map cell type-specific gene expression and validate in vitro recapitulation of human SAN signatures.

Core Findings and Why They Matter

This assembloid platform demonstrates integrated molecular, morphological, and electrophysiological features of human SAN activity, including spontaneous diastolic depolarization and region-specific conduction. Functional experiments revealed that neural innervation from CGPOs enhances pacemaker cell maturation, increases the robustness of automaticity, and supports physiological conduction to atrial-like tissue. Critically, the study identifies CGPO-derived PSAP as a key paracrine factor that signals via the GPR37 receptor, driving the maturation of SAN pacemaker properties. The integration of spatial transcriptomics with functional assays substantiates that the model faithfully mirrors human SAN architecture and neuron-to-pacemaker signaling dynamics (reference study).

These advances address limitations of prior hPSC-based and cardiac organoid models, which have lacked either neural inputs or full 3D spatial organization. The new system provides a versatile tool for dissecting mechanisms underlying pacemaker development, disease, and pharmacological modulation of beta-adrenergic receptor signaling.

Comparison with Existing Internal Articles

Several internal resources have explored related experimental workflows and protocol optimizations:

• The article Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids provides an accessible overview of how assembloid systems can be applied to dissect neuron-pacemaker signaling and conduction disorders in human tissue.
• Isoproterenol Sulfate Dihydrate: Enabling Human Pacemaker Research details stepwise protocols for modeling beta-adrenergic receptor signaling in assembloid platforms, emphasizing reproducibility and troubleshooting strategies that complement the reference study’s workflow.
• For practical guidance on optimizing beta-adrenergic stimulation in assembloids, Isoproterenol Sulfate Dihydrate in Human Cardiac Assembloid Research discusses protocol enhancements and workflow adaptation, reinforcing the importance of high-purity agonists for reliable signaling assays.

Collectively, these resources bridge protocol optimization with mechanistic discovery, supporting the implementation and scaling of assembloid-based neuro-cardiac research workflows.

Limitations and Transferability

Despite its strengths, the reference assembloid model faces several limitations. The degree of cellular and structural complexity, while advanced, still does not fully capture the intricacies of in situ SAN innervation and anatomical context. The model’s reliance on hPSC differentiation protocols introduces donor and line-dependent variability, potentially affecting reproducibility across laboratories. Additionally, while the platform enables robust functional interrogation of GPCR signaling and cAMP/PKA pathway modulation, long-term maturation and integration with vascular or immune components remain underexplored. The transferability of findings to adult and diseased human SAN physiology necessitates further validation using primary tissue and in vivo correlates.

Research Support Resources

Researchers interested in modeling beta-adrenergic receptor signaling or pharmacological modulation within human cardiac assembloid systems can leverage high-purity reagents such as Isoproterenol sulfate dihydrate (SKU C6402) from APExBIO. As a non-selective beta-adrenergic agonist, it enables controlled stimulation of GPCR signaling pathways relevant to SAN function, with well-documented solubility and stability parameters (internal workflow resource). When designing assembloid-based cardiovascular research protocols, attention to compound purity, storage, and handling is essential for reproducibility and data quality.